Corticotropin-releasing factor neurons in the hypothalamic paraventricular nucleus are involved in arousal/yawning response of rats.
Our previous studies have suggested that activation of the hypothalamic paraventricular (PVN) descending oxytocinergic projections is involved in the induction of yawning accompanied by an arousal response, but the possibility that neural systems other than the oxytocinergic system in the PVN also mediate the arousal/yawning response cannot be ruled out. We assessed the activity of corticotropin-releasing factor (CRF) neurons during yawning induced by the PVN stimulation in anesthetized, spontaneously breathing rats using double-staining for c-Fos and CRF. Yawning response was evaluated by monitoring an intercostals electromyogram as an index of inspiratory activity and a digastric electromyogram as an indicator of mouth opening. We also recorded the electrocorticogram (ECoG) to determine the arousal response during yawning. Microinjection of l-glutamate (2-5 nmol) into the PVN produced a frequent yawning accompanied by an arousal shift in the ECoG, and these behavioral effects were associated with a significant increase of c-Fos positive CRF neurons in the medial parvocellular subdivision of the PVN. In addition, a marked enhancement in the c-Fos expression was found in the both locus coeruleus (LC) and global area in the cortex when the frequency of yawning response was increased by the PVN stimulation, suggesting that the arousal response during yawning might be mediated by the activation of LC neurons. The present study suggests that an activation of CRF neurons in the PVN is responsible for the arousal response accompanied by yawning behavior.
Kita
Ichiro
I
Department of Physiology, Toho University School of Medicine, 5-21-16 Omori-nishi, Ohta-ku, Tokyo 143-8540, Japan.
Seki
Yoshinari
Y
Nakatani
Yasushi
Y
Fumoto
Masaki
M
Oguri
Mitsugu
M
Sato-Suzuki
Ikuko
I
Arita
Hideho
H
D000704:Analysis of Variance; D000818:Animals; D001143:Arousal / Q000502:physiology*; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism*; D004576:Electromyography; D018698:Glutamic Acid / Q000008:administration & dosage; D007150:Immunohistochemistry; D007366:Intercostal Muscles / Q000502:physiology; D008125:Locus Coeruleus / Q000378:metabolism; D008297:Male; D008845:Microinjections; D009474:Neurons / Q000378:metabolism*; D010286:Paraventricular Hypothalamic Nucleus / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D013239:Stereotyped Behavior / Q000502:physiology; D015000:Yawning / Q000502:physiology*
D016760:Proto-Oncogene Proteins c-fos; D018698:Glutamic Acid; D003346:Corticotropin-Releasing Hormone